MIRA INFORM REPORT

 

 

Report No. :

348339

Report Date :

06.11.2015

 

 IDENTIFICATION DETAILS

 

Name :

MEDICAPS LIMITED

 

 

Registered Office :

Mhow-Neemuch Road, Sector-1, Pithampur - 454 775, Disttrict Dhar, Madhya Pradesh

Tel. No.:

91-7292-424242/ 407445/407446/253596

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

06.08.1983

 

 

Com. Reg. No.:

10-002231

 

 

Capital Investment / Paid-up Capital :

Rs. 124.699 Million

 

 

CIN No.:

[Company Identification No.]

L24232MP1983PLC002231

 

 

IEC No.:

1189002078

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BPLM01282B

 

 

PAN No.:

[Permanent Account No.]

AABCM1905G

 

 

Legal Form :

A Public Limited Liability company. The company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Capsules

 

 

No. of Employees :

215 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (36)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 1800000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated on 6th August, 1983 as a private limited company and was converted into public limited on 3rd March, 1986. It is engaged into business of manufacturing of Empty Hard Gelatine Capsule (EHGC). It has moderate track record.

 

The company possesses a decent financial profile marked by adequate networth base, zero debt, good profitability and fair liquidity.

 

Further, the ratings also take into consideration, a minimal share price of Rs. 19.15/- recorded by the company as against a face value of Rs. 10 as on November 5, 2015.

 

Trade relations are fair. Business is active. Payment are reported to be slow but correct.

 

The company can be considered normal for business dealings with some cautions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Amit Parmar

Designation :

Assistant Account Manager

Contact No.:

91-7292-407445/ 407446

Date :

05.11.2015

 

 

LOCATIONS

 

Registered Office / Factory :

Mhow-Neemuch Road, Sector-1, Pithampur 454 775, Disttrict Dhar, Madhya Pradesh, India

Tel. No.:

91-7292-424242/ 407445/407446/253596

Fax No.:

91-7292-407387/ 424242

E-Mail :

info@medicaps.com

purchase@medicaps.com

indore@medicaps.com

accounts@medicaps.com

investors@medicaps.com

medicaps@bom4.vsnl.net.in

Website :

http://www.medicaps.com

Location :

Owned

 

 

Corporate Office :

201, Pushpratna Paradise, 9/5, New Palasia, Indore-452001, Madhya Pradesh, India

Tel. No.:

91-731-4046321/ 4041435

Fax No.:

91-731-4041435

Email. :

indore@medicaps.com

Website :

www.medicaps.com

 

 

DIRECTORS

 

As on: 31.03.2015

 

Name :

Mr. Ramesh C. Mittal 

Designation :

Chairman and Managing Director

Date of Birth

16.06.1947

Qualification:

B. Pharma

PAN No. :

ABZPM1785C

Date of Appointment :

06.08.1983

DIN No.:

00035272

 

 

Name :

Mr. Alok K. Garg

Designation :

Whole Time Director

Date of Birth

27.04.1969

Qualification:

B.A. (Honors), MBA (Marketing), Diploma in Export Documentation & Implementation from IIFT, Delhi

PAN No. :

AAHPG5352J

Date of Appointment :

01.04.1999

DIN No.:

00274321

 

 

Name :

Mrs. Kusum Mittal   

Designation :

Whole Time Director

Date of Birth

08.08.1950

Qualification:

B.A

PAN No. :

ABZPM1784D

Date of Appointment :

04.05.1991

DIN No.:

00035356

 

 

Name :

Mrs. Trapti Vikas  Gupta 

Designation :

Director

Date of Birth

30.04.1977

Qualification:

MBA Finance

PAN No. :

AENPM0248M

Date of Appointment :

30.01.2009

DIN No.:

00204741

 

 

Name :

Dr. Shashikant Sharma

Designation :

Director

Date of Birth

05.03.1947

Qualification:

MBBS

PAN No. :

AGTPS5397P

Date of Appointment :

29.06.1993

DIN No.:

00204610

 

 

Name :

Dr. Shamsher Singh      

Designation :

Director

Date of Birth

06.06.1942

Qualification:

B.E. M.E. and Ph. D.

PAN No. :

AGAPS8548P

Date of Appointment :

30.04.2009

DIN No.:

00204290

 

 

Name :

Dr. Keshav Singh  Verma

Designation :

Director

PAN No. :

ACIPV0319H

Date of Appointment :

30.04.2007

DIN No.:

01490522

 

 

Name :

Dr. Vishwanath Balkrishna Malker

Designation :

Director

PAN No. :

ABVPM7903Q

Date of Appointment :

Up to 29.05.2014

DIN No.:

02491684

 

 

Name :

Shri Pramod Fatehpuria

Designation :

Independent Director

Date of Appointment :

29.05.2014

Qualification:

B. com

Date of Birth

02.11.1961

DIN No.:

00972389

 

 

KEY EXECUTIVES

 

Name :

Mr. Amit Parmar

Designation :

Assistant Account Manger

 

 

Name :

Shri Ashok R. Pitliya

Designation :

General Manager Finance - Member

 

 

Name :

Shri Manish Kumar Jain

Designation :

Chief Financial Officer

 

 

Name :

Mr. Rajat Gupta

Designation :

Secretary and Head Compliance

Address :

211, Gumasta Nagar, Indore-452001, Madhya Pradesh, India

 

 

Name :

Ishan Jain and Company

Designation :

Company Secretaries

Address :

401, Silver Ark Plaza, 20/1, New Palasia, Indore-452001, Madhya Pradesh, India

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON:  30.09.2015

 

Category of Shareholder

Total No. of Shares

As a %

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

5938656

47.62

http://www.bseindia.com/include/images/clear.gifBodies Corporate

307128

2.46

http://www.bseindia.com/include/images/clear.gifSub Total

6245784

50.09

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

6245784

50.09

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

0

0.04

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

0

0.23

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.27

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

652504

5.34

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

2563865

24.73

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

2230774

18.07

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

161357

1.50

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

133830

1.28

http://www.bseindia.com/include/images/clear.gifClearing Members

27527

0.22

http://www.bseindia.com/include/images/clear.gifSub Total

5608500

49.64

Total Public shareholding (B)

5608500

49.91

Total (A)+(B)

11854284

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1)

0

0.00

http://www.bseindia.com/include/images/clear.gif(2)

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

11854284

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Capsules

 

 

Products :

Products Description 

Products Description 

Hard Gelatin Capsule Shells I.P.

9602 0030

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

215 (Approximately)

 

 

Bankers :

  • IDBI Bank Limited
  • IndusInd Bank Limited
  • State Bank of India
  • Citibank N.A. Limited

 

 

Facilities :

--

 

Auditors :

 

Name :

C P Rawka and Company

Chartered Accountants

Address :

403, Acrcade Sliver, 56,1, New Palasia, Indore - 452 001, Madhya Pradesh, India

Tel. No.:

91-731-2541132

Fax No.:

91-731-4215397

E-Mail :

cp_rawka@yahoo.com

 

 

Internal Auditor

 

Name :

Praveen Shrivastava and Company

Chartered Accountants

Address :

208, Sapana Chamber, 12/1 South Tukoganj, Behind Shreemaya Hotel, Indore - 452 001, Madhya Pradesh, India

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiaries :

Medgel Private Limited (U24239MP2007PTC019204)

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs.10/- each

Rs.150.000 Million

 

 

 

 

 

Issued Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

13021047

Equity Shares

Rs.10/- each

Rs. 130.210 Million

 

 

 

 

 

Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

12469956

Equity Shares

Rs.10/- each

Rs. 124.699 Million

 

 

 

 

 

Details of shareholders holding more than 5 percent share in the company

Name of shareholders

No. of shares

% of Holding

R.C. Mittal

3166320

25.40%

Kusum Mittal

2700136

21.65%

 

 

Reconciliation of the number of shares outstanding at the beginning and the end of the reporting period:

 

 

31.03.2015

 

No. of Shares held

Rs. in Million

Equity Shares of Rs. 10

At the beginning of the period

12469956

124.699

Issued during the period

--

 

 

 

 

Outstanding at the end of the period

12469956

124.699

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

124.699

124.699

124.699

(b) Reserves & Surplus

518.863

499.502

498.075

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

643.562

624.201

622.774

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

3.394

2.915

2.048

(c) Other long term liabilities

0.000

0.763

0.763

(d) long-term provisions

7.551

6.636

5.538

Total Non-current Liabilities (3)

10.945

10.314

8.349

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

12.214

11.727

5.337

(c) Other current liabilities

15.238

17.268

15.475

(d) Short-term provisions

7.500

10.000

12.000

Total Current Liabilities (4)

34.952

38.995

32.812

 

 

 

 

TOTAL

689.459

673.510

663.935

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

39.648

40.013

42.762

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

465.420

302.732

323.204

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term Loan and Advances

4.107

54.202

54.203

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

509.175

396.947

420.169

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

17.110

114.809

14.316

(b) Inventories

70.592

54.398

41.295

(c) Trade receivables

66.365

80.023

67.455

(d) Cash and cash equivalents

8.955

7.966

7.504

(e) Short-term loans and advances

17.262

19.367

113.196

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

180.284

276.563

243.766

 

 

 

 

TOTAL

689.459

673.510

663.935

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Income

273.631

273.698

260.251

 

 

Other Income

12.059

(15.619)

(13.325)

 

 

TOTAL                                    

285.690

258.079

246.926

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

143.654

124.829

112.458

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

      (10.937)

(7.534)

(16.239)

 

 

Employees benefits expense

49.289

47.257

44.674

 

 

Other expenses

73.148

77.876

81.572

 

 

TOTAL                                    

255.154

242.428

222.465

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

30.536

15.651

24.461

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

3.196

3.404

6.286

 

 

 

 

 

 

PROFIT BEFORE TAX

27.340

12.247

18.175

 

 

 

 

 

Less

TAX                                                     

7.979

10.821

11.518

 

 

 

 

 

 

PROFIT AFTER TAX

19.361

1.426

6.657

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

461.868

460.442

433.173

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

481.229

461.868

460.442

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

15.257

15.509

6.211

 

 

 

 

 

 

IMPORT

 

 

 

 

 

Raw Materials

0.000

12.818

16.808

 

 

Capital Goods

0.246

0.263

0.208

 

TOTAL IMPORT

0.246

13.081

17.016

 

 

 

 

 

 

Earnings Per Share (Rs.)

1.55

0.11

0.53

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

76.310

(5.752)

(127.278)

Net Cash flows from operating activities

68.810

(15.704)

(139.278)

 

 

    QUARTERLY RESULTS

 

 

 

PARTICULARS

 

 

 

1 Quarter

Unaudited

 

 

30.06.2015

Net Sales

 

 

69.090

Total Expenditure

 

 

(64.170)

PBIDT (Excl OI)

 

 

4.910

Other Income

 

 

0.000

Operating Profit

 

 

4.910

Interest

 

 

0.000

Exceptional Items

 

 

0.000

PBDT

 

 

4.910

Depreciation

 

 

(0.810)

Profit Before Tax

 

 

4.100

Tax

 

 

(1.200)

Provisions and contingencies

 

 

0.000

Profit After Tax

 

 

2.900

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

7.08

0.52

10.56

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

11.16

5.72

19.94

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.20

3.30

13.68

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.04

0.02

0.07

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

5.16

7.09

5.64

 

 

STOCK PRICES

 

Face Value

Rs. 10/-

Market Value

Rs.19.15/-

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

31.175

124.699

124.699

Reserves & Surplus

584.943

499.502

518.863

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

616.118

624.201

643.562

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

258.211

273.697

273.631

 

 

5.997

(0.024)

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

258.211

273.697

273.631

Profit

27.269

1.426

19.361

 

10.56%

0.52%

7.08%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

---

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

---

33

Market information

---

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

ECONOMIC SCENARIO AND OUTLOOK:

 

With India expected to 'turn the corner' on the back of structural reforms, its economy is projected to clock 7 per cent growth in 2015 even as China would see an economic slowdown, says a study. Presenting predictions by its economists for the New Year, global consultancy PwC said India is expected to resume growing at more than 6 per cent after seeing expansion below this level since 2012."We think 2015 could be the year that India turns the corner, posting growth of around 7 per cent. In the short term, low oil prices are likely to increase GDP growth, ease the pressures of India's high current account deficit and help bring down inflation," it said. Regarding the country's medium-term economic prospects, PwC said, "They think that the February 2015 budget could see India take a step towards implementing new structural reforms which will boost the economy."

 

India's economic growth was below 5 per cent in the last two financial years. The Reserve Bank of India (RBI) forecast the economy to grow at 5.5 per cent in 2014-15 (ending this March) and at 6.3 per cent in next financial year 2015-16

 

 

PHARMACEUTICAL INDUSTRY OUTLOOK AND OPPORTUNITIES

 

The global pharmaceutical market seems to be showing signs of recovery with several positive factors projected for the next four to five years. Global spending on medicines is expected to reach US$ 1.3 trillion by 2018, representing a compounded annual growth rate (CAGR) varying between 5-6% on a constant currency basis for the forecast period of 2014-2018. This is slightly higher than the 5.2% growth rate recorded over the past five years.

 

Higher growth is primarily on account of general economic wellbeing, the effect of aging populations and chronic/lifestyle diseases on the demand side — and the introduction of new specialty medicines and increased accessibility of patients to medical infrastructure and funding, expansion of emerging markets and advances in treatment and allied technologies on the supply side.

 

On a regional basis, healthcare spending in North America is expected to increase on an average by approximately 5% per year during 2014-2018. This expenditure is expected to be partly driven by expanded consumer access to healthcare through the 2010 Patient Protection and Affordable Care Act; and partly because of the introduction of new medicines as well as the general economic recovery of the area.

 

 

INDEX OF CHARGES:

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

90207759

22/01/1996

11,500,000.00

I.D.B.I. BANK LIMITED

ALANKAR CHAMBERS, RATLAM KOTHI, A.B. ROAD, INDORE – 452001, MADHYA PRADESH, INDIA

-

2

90207250

24/03/1992

300,000.00

BANK OF BARODA

R.N.T. MARG, INDORE, MADHYA PRADESH, INDIA

-

3

90202622

05/10/1990

1,000,000.00

BANK OF BARODA

R.N.T. MARG, INDORE, MADHYA PRADESH, INDIA

-

4

90204557

24/07/1986

700,000.00

BANK OF BARODA

R.N.T. MARG, INDORE, MADHYA PRADESH, INDIA

-

5

90202201

28/01/1991 *

9,000,000.00

M.P. AUDYOGIK VIKAS NIGAM LIMITED

PANCHANAN; 2 – ND FLOOR, MALVIYA NAGAR, BHOPAL, MADHYA PRADESH, INDIA

-

 

 

* Date of charge modification

 

 

FIXED ASSETS:

 

  • Free Hold Land
  • Building
  • Plant and Machinery
  • Furniture and Fixture
  • Vehicles
  • Computers

 

 

STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2015

 

 

Sr. No.

 

Particulars

Rs in Million

Quarter ended

as on 30.06.2015

(Unaudited)

1

(a) Net Sales/Income from Operations

68.221

 

(b)Other Operating Income

0.866

 

Total Income From Operations (Net)

69.087

2

Expenditure

 

 

(a)

Cost of Materials Consumed

33.236

 

(b)

Purchases of Stock-in-Trade

0.000

 

(c)

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

0.952

 

(d)

Employees benefits expense

12.586

 

(e)

Power Cost

8.958

 

(f)

Depreciation and amortization expense

0.804

 

(g)

Other expenses

8.445

 

 

TOTAL (B)

64.985

 

 

 

3

Profit from operation before other income, interest and other exceptional items(1-2)

4.102

4

Other Income

0.00

5

profit before interest and exceptional items(3+4)

4.102

6

Interest

0.000

7

Profit after interest but before exceptional items(5-6)

4.102

8

Exceptional Items

0.000

9

Profit(+)/Loss(-) from Ordinary Activities before tax (7-8)

4.102

10

Tax Expenses

1.200

11

Net Profit(+)/Loss(-) from Ordinary Activities after tax( 9-10)

2.902

12

Extra Ordinary Items

0.000

13

Net Profit(+)/Loss(-) for the period (11­12)

2.902

14

Paid-up Equity Share Capital Rs.10/ per share

124.700

15

Reserves excluding revaluation reserves

--

16

Earnings Per Share

 

(a)

Basic and diluted EPS before Extraordinary items for the period, for the year to date and for the previous year(not to be annualised)

0.23

(b)

 Basic and diluted EPS after Extraordinary items for the period, for the year to date and for the previous year(not to be annualised)

0.23

17

Public Shareholding

 

 

Number of Shares

6.224

 

Percentage of Shareholding

4.991

18

Promoters and Promoter group

 

 

a) Pledged/Encumbered

0.000

 

Number of shares

0.000

 

Percentage of Shares (as a % of the total shareholding of promoter and promoter group)

0.000

 

Percentage of Shares (as a % of the total share capital of the Company)

 

 

b) Non-encumbered

 

 

Number of shares

6.246

 

Percentage of Shares (as a % of the total shareholding of promoter and promoter group)

100.00

 

Percentage of Shares (as a % of the total share capital of the Company)

50.09

 

Particulars

3 months

ended

30.06.2015

 

INVESTOR COMPLAINTS

 

 

Pending at the beginning of the quarter

0

 

Received during the quarter

0

 

Disposed off during the quarter

0

 

Remaining unresolved at the end of the quarter

0

 

Notes:

  1. The above unaudited results have been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on August 12, 2015.

 

  1. The statutory auditors of the Company have carried out a limited review of the standalone financial      statement of the Company for the above said quarter and were also approved by the Board. There is no qualification in the limited, Review for the quarter ended June 30, 2015.
  2. The Company has decided to declare unaudited standalone financial results for the 1,2 and 3 quarter hence the Item No. 14 to 15 is not applicable in the above said quarter

 

  1. The Company is dealing only in one segment.
  2.  Figures have been rearranged as per requirements.

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs.65.68

UK Pound

1

Rs.101.02

Euro

1

Rs.71.35

 

 

INFORMATION DETAILS

 

Information Gathered by :

SPY

 

 

Analysis Done by :

RSM

 

 

Report Prepared by :

MTN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILITY

1~10

4

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

5

--RESERVES

1~10

3

--CREDIT LINES

1~10

4

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

36

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.